in , , ,

VP Leni Robredo haters try to discredit molnupiravir achievement

Molnupiravir prevents patients from getting hospitalized in early stages of infection

Critics of Vice President Leni Robredo try to downplay her achievement of making anti-viral drug molnupiravir available through her office.

The Office of the Vice President (OVP) recently signed a memorandum of agreement with QualiMed Health Network to help patients who have been given the green light to take the drug.

Molnupiravir is used for those suffering mild to moderate symptoms related to COVID-19.

The OVP’s telemedicine program, Bayanihan E-Konsulta, would review cases virtually and provide the drug for anyone qualified.

“We are truly humbled and grateful to the QualiMed Health Network for trusting us with this partnership, helping us extend our reach in delivering aid to more of our kababayans in need. Maraming, maraming salamat po!” she said in a social media post.

Molnupiravir also prevents patients from getting hospitalized in the early stages of infection.

The United Kingdom first approved the anti-viral pill jointly developed by US-based Merck and Ridgeback Biotherapeutics.

Before the OVP secured the deal, FDA Director-General Eric Domingo said people could acquire the drug under a compassionate special permit.

However, those who didn’t like Robredo decided to discredit her office’s achievement.

Controversial health expert Edsel Salvana went on Facebook and warned the public that the drug could potentially be dangerous. It seemed to the netizens that he didn’t read Robredo’s post carefully.

Another health expert warned against using the drug but was fact-checked by fellow doctors.

Other netizens also questioned Robredo’s accomplishment.


Written by JO-EST B. TAN

0917 159 6675

11 Housemates who exited voluntarily from the ‘Pinoy Big Brother’ house

ABS-CBN airing Rep. Dante Marcoleta’s ad proves the network is unbiased